Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmEnrolling by invitationPhase 22026-10-05NCT06773936

2 results · Page 1 of 1

Swipe the table sideways for more columns.

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Banner University Medical Center - TucsonTucsonUnited States161
Baptist Memorial Health CareMemphisUnited States1
Cleveland Clinic FoundationClevelandUnited States370
Duke University Medical CenterDurhamUnited States505
Henry Ford HospitalDetroitUnited States326
Nebraska Medicine-BellevueBellevueUnited States91
Nebraska Medicine-Village PointeOmahaUnited States102
Northwell Health/Center for Advanced MedicineLake SuccessUnited States117
Rhode Island HospitalProvidenceUnited States229
UC Irvine Medical CenterOrangeUnited States19
University of Arizona Cancer Center - North CampusTucsonUnited States5
University of Cincinnati Cancer Ctr-UC Medical CtrCincinnatiUnited States1
University of Nebraska Medical CenterOmahaUnited States397
University of New Mexico Cancer CenterAlbuquerqueUnited States43
University of Rochester Medical CenterRochesterUnited States162
UPMC Hillman Cancer CenterPittsburghUnited States330